Thyroid autoantibodies and thyroid dysfunction during treatment with interferon-α for chronic hepatitis C
✍ Scribed by Karlheinz Kiehne; Sievert Kloehn; Holger Hinrichsen; Baptist Gallwitz; Heiner Mönig
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 445 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0969-711X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The development of autoantibodies and autoimmune reactions has been reported during and after interferon (IFN) therapy. Thirteen different antibodies from the sera of 32 patients with chronic hepatitis B treated with alpha-interferon (alpha-IFN) were tested. Seventeen HBeAg-positive patients receive
Recombinant human a-interferon is now under intensive investigation as therapy for chronic Type B hepatitis. Recent reports have suggested that prolonged a- interferon therapy may induce autoimmune reactions. We have evaluated the problem of autoimmunity related to a-interferon therapy by testing fo
Twelve children with chronic non-A, non-B hepatitis were entered in a pilot trial of recombinant interferon-alpha. Although all the children had hepatitis C virus RNA in serum, only five had antibodies against this virus. Children received 3 MU/m2 body surface area interferon-alpha 3 times/wk for 6